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Recent molecular profiling studies of paediatric high grade (pHGG) and
diffuse intrinsic pontine glioma (DIPG) have refined these tumours into
age- and location-based subgroups driven by unique genetic and epigenetic al-
terations, however individual studies are underpowered to investigate
subgroup-specific events. We have retrieved publicly available genome-wide
data from560 pHGG/DIPG samples and combined this with140 unpub-
lished cases including young adults up to the age of 30 years.Wehave integrat-
ed multiple array-based and sequencing platforms to produce DNA copy
number profiles from 700 tumours, 500 with clinicopathological and
histone H3 annotation, and .300 of which have full somatic sequence infor-
mation.We identified subgroup-specific genetic alterations co-segregating, or
mutually exclusive, with known driving histonemutations. H3.3G34R/V ce-
rebral hemispheric tumours harbour significantly more CNAs and SNVs than
other subgroups. These included novel amplified loci at 1p13.3 (KCNA) and a
histone cluster at 6p22.2, though lacked key amplified loci such as MYC/
MYCN. H3.1K27M DIPG were distinct from H3.3K27M primarily on the
basis of whole arm chromosomal changes (enriched +2, -16q; reduced -17p
anda lackofTP53mutations).H3.3K27Mtumoursharboured specifically en-
riched known (7q31.2;MET) and novel amplicons (17p11.2;TOP3A).
Integration with mutation data identified subgroup-independent, non-
overlapping pathway-level recurrent alterations, such as RTK-PI3K-mTOR,
dysregulated in 55% cases and conferring shorter survival in hemispheric,
but not other locations. Aswell as inter-tumoral differences, deeper interroga-
tion of the sequencing data also reveals substantial intra-tumoral heterogene-
ity.Whilst driving histoneH3mutations were found to be present in 100% of
cells, mutations in genes such as PDGFRA and PIK3CA were predominantly
found at subclonal levels, and tumours from all locations were inferred to be
comprised ofmultiple subclonal populations,withH3.3G34R/V themost ge-
netically diverse. These data improve our understanding of the underlying
biology of pHGG/DIPG, and will provide rational targets for subgroup-
specific and –independent therapies.
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